ArticleAnalytical and bioanalytical chemistry2026
A point-of-care testing platform for pathogen nucleic acid analysis utilizing paper-based extraction and portable qPCR.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Rapid and reliable diagnostic methods are crucial for controlling animal disease outbreaks and reducing mortality, especially when effective drugs or vaccines are unavailable. While real-time quantitative polymerase chain reaction (qPCR) remains the gold standard for nucleic acid detection due to its superior sensitivity and specificity, conventional workflows are inherently cumbersome. Traditional extraction and amplification processes typically require 1.5 to 3 h, with further delays incurred by transporting samples to centralized laboratories. To overcome these limitations, this study introduces a point-of-care testing platform for on-site pathogen diagnostics. This system synergistically combines a centrifuge-free, glass fiber (GF) paper-based nucleic acid extraction card, room-temperature-stable lyophilized qPCR reagents, and a portable qPCR instrument. By eliminating the dependency on bulky benchtop equipment and cold-chain logistics, this platform streamlines lysis, extraction, and amplification, delivering sample-to-answer results within 45 min. The optimized system demonstrated excellent analytical sensitivity, achieving limits of detection (LoDs) of 10 copies/μL for the N gene of porcine epidemic diarrhea virus (PEDV) and 50 copies/μL for the PirA gene of Vibrio parahaemolyticus AHPND (VP
Indexed as
Identifiers
42581111What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.